Moleculin Biotech, Inc.·4

Jun 23, 4:34 PM ET

PICKER DONALD H 4

4 · Moleculin Biotech, Inc. · Filed Jun 23, 2025

Insider Transaction Report

Form 4
Period: 2025-06-20
Transactions
  • Exercise/Conversion

    Common Stock

    2025-06-20+1,0789,079 total
  • Tax Payment

    Common Stock

    2025-06-20$0.27/sh263$708,816 total
  • Tax Payment

    Common Stock

    2025-06-22$0.27/sh430$11510,152 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-201,078106,024 total
    Common Stock (1,078 underlying)
  • Exercise/Conversion

    Common Stock

    2025-06-22+1,76610,582 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-221,766104,258 total
    Common Stock (1,766 underlying)
Footnotes (4)
  • [F1]Restricted stock units convert into common stock on a one-for-one basis.
  • [F2]Shares withheld for payment of taxes upon vesting of restricted stock unit awards.
  • [F3]On June 20, 2022, the reporting person was granted 4,312 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
  • [F4]On June 22, 2023, the reporting person was granted 7,063 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file
  • 4
    rdgdoc.xmlPrimary

    FORM 4